C-Rad AB (LTS:0R44) FFO


LTS:0R44 C-Rad AB LTS:0R44
83 GF Score
Price kr35.90
GF Value kr31.78
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is C-Rad AB FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0R44
83GF Score
C-Rad AB LTS:0R44
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is C-Rad AB (LTS:0R44) Overvalued in 2026?

Based on GuruFocus' analysis, C-Rad AB stock appears to be overvalued. The current stock price of kr35.90 is trading 13% above its estimated GF Value™ of kr31.78. GuruFocus considers C-Rad AB to be Fairly Valued.

Key valuation signals for LTS:0R44:

  • FFO:
  • GF Value™: kr31.78 vs. price of kr35.90 (13% above fair value)
  • GF Score™: 83/100 with 4 warning signs

No single metric tells the full story. See the LTS:0R44 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

C-Rad AB Business Description

Other Exchanges CRAD B:Sweden24C:Germany
Address Sjukhusvagen 12K, Uppsala, SWE, 753 09
C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Asia Pacific region, and also has its presence in Europe, Middle East and Africa and the rest from Americas.
83GF Score

Get the complete analysis for LTS:0R44

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr35.90
Price
kr31.78
GF Value